APO Research

APO RESEARCH · REPORT

Gleevec

Selected research

Market Outlook & Growth Opportunities

Global Gleevec Market Outlook and Growth Opportunities 2026

Market perspective

The global Gleevec market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gleevec is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gleevec market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gleevec market include Novartis. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gleevec market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gleevec and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gleevec sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gleevec market size, projected growth trends, production technologies, key applications, and end-use industries.

Gleevec Segment by Company

Novartis

Gleevec Segment by Type

400mg

100mg

Gleevec Segment by Application

Hospital

Pharmacy

Gleevec Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gleevec status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gleevec market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gleevec significant trends, drivers, influence factors in global and regions.

6. To analyze Gleevec competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gleevec market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gleevec and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gleevec.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gleevec market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gleevec industry.

Chapter 3: Detailed analysis of Gleevec manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gleevec in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gleevec in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gleevec Industry Trends Table 2. Gleevec Industry Drivers Table 3. Gleevec Industry Opportunities and Challenges Table 4. Gleevec Industry Restraints Table 5. Global Gleevec Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gleevec Revenue Share by Company (2021-2026) Table 7. Global Gleevec Sales Volume by Company (k units) & (2021-2026) Table 8. Global Gleevec Sales Volume Share by Company (2021-2026) Table 9. Global Gleevec Average Price (US$/unit) of Company (2021-2026) Table 10. Global Gleevec Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gleevec Key Company Manufacturing Base & Headquarters Table 12. Global Gleevec Company, Product Type & Application Table 13. Global Gleevec Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gleevec by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 400mg Table 18. Significant Companies of 100mg Table 19. Global Gleevec Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Gleevec Sales Volume by Type (2021-2026) & (k units) Table 21. Global Gleevec Sales Volume by Type (2027-2032) & (k units) Table 22. Global Gleevec Sales Volume Share by Type (2021-2026) Table 23. Global Gleevec Sales Volume Share by Type (2027-2032) Table 24. Global Gleevec Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gleevec Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gleevec Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gleevec Sales Value Share by Type (2021-2026) Table 28. Global Gleevec Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Pharmacy Table 31. Global Gleevec Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Gleevec Sales Volume by Application (2021-2026) & (k units) Table 33. Global Gleevec Sales Volume by Application (2027-2032) & (k units) Table 34. Global Gleevec Sales Volume Share by Application (2021-2026) Table 35. Global Gleevec Sales Volume Share by Application (2027-2032) Table 36. Global Gleevec Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Gleevec Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Gleevec Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Gleevec Sales Value Share by Application (2021-2026) Table 40. Global Gleevec Sales Value Share by Application (2027-2032) Table 41. Global Gleevec Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Gleevec Sales by Region (2021-2026) & (k units) Table 43. Global Gleevec Sales Market Share by Region (2021-2026) Table 44. Global Gleevec Sales by Region (2027-2032) & (k units) Table 45. Global Gleevec Sales Market Share by Region (2027-2032) Table 46. Global Gleevec Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Gleevec Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Gleevec Sales Value Share by Region (2021-2026) Table 49. Global Gleevec Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Gleevec Sales Value Share by Region (2027-2032) Table 51. Global Gleevec Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Gleevec Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Gleevec Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Gleevec Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Gleevec Sales by Country (2021-2026) & (k units) Table 56. Global Gleevec Sales Market Share by Country (2021-2026) Table 57. Global Gleevec Sales by Country (2027-2032) & (k units) Table 58. Global Gleevec Sales Market Share by Country (2027-2032) Table 59. Global Gleevec Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Gleevec Sales Value Market Share by Country (2021-2026) Table 61. Global Gleevec Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Gleevec Sales Value Market Share by Country (2027-2032) Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Gleevec Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Novartis Gleevec Product Portfolio Table 67. Novartis Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Gleevec Distributors List Table 71. Gleevec Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Gleevec Product Image Figure 2. Global Gleevec Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gleevec Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gleevec Sales (2021-2032) & (k units) Figure 5. Global Gleevec Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Gleevec Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 400mg Image Figure 10. 100mg Image Figure 11. Global Gleevec Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Gleevec Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gleevec Sales Volume Share by Type (2021-2032) Figure 14. Global Gleevec Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gleevec Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gleevec Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Global Gleevec Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Gleevec Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Gleevec Sales Volume Share by Application (2021-2032) Figure 22. Global Gleevec Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gleevec Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Gleevec Sales Value Share by Application (2021-2032) Figure 25. Global Gleevec Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Gleevec Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Gleevec Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Gleevec Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Gleevec Sales Value (2021-2032) & (US$ Million) Figure 30. North America Gleevec Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Gleevec Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Gleevec Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Gleevec Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Gleevec Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Gleevec Sales Value (2021-2032) & (US$ Million) Figure 36. South America Gleevec Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Gleevec Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Gleevec Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Gleevec Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Gleevec Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Gleevec Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Gleevec Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Gleevec Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 400mg
  • 100mg
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gleevec Sales Value (2021-2032)
  4. 1.2.2 Global Gleevec Sales Volume (2021-2032)
  5. 1.2.3 Global Gleevec Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gleevec Market Dynamics
  1. 2.1 Gleevec Industry Trends
  2. 2.2 Gleevec Industry Drivers
  3. 2.3 Gleevec Industry Opportunities and Challenges
  4. 2.4 Gleevec Industry Restraints
3 Gleevec Market by Company
  1. 3.1 Global Gleevec Company Revenue Ranking in 2025
  2. 3.2 Global Gleevec Revenue by Company (2021-2026)
  3. 3.3 Global Gleevec Sales Volume by Company (2021-2026)
  4. 3.4 Global Gleevec Average Price by Company (2021-2026)
  5. 3.5 Global Gleevec Company Ranking (2024-2026)
  6. 3.6 Global Gleevec Company Manufacturing Base and Headquarters
  7. 3.7 Global Gleevec Company Product Type and Application
  8. 3.8 Global Gleevec Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gleevec Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gleevec Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gleevec Market by Type
  1. 4.1 Gleevec Type Introduction
  2. 4.1.1 400mg
  3. 4.1.2 100mg
  4. 4.2 Global Gleevec Sales Volume by Type
  5. 4.2.1 Global Gleevec Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gleevec Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gleevec Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gleevec Sales Value by Type
  9. 4.3.1 Global Gleevec Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gleevec Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gleevec Sales Value Share by Type (2021-2032)
5 Gleevec Market by Application
  1. 5.1 Gleevec Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Gleevec Sales Volume by Application
  5. 5.2.1 Global Gleevec Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gleevec Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Gleevec Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Gleevec Sales Value by Application
  9. 5.3.1 Global Gleevec Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Gleevec Sales Value by Application (2021-2032)
  11. 5.3.3 Global Gleevec Sales Value Share by Application (2021-2032)
6 Gleevec Regional Sales and Value Analysis
  1. 6.1 Global Gleevec Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gleevec Sales by Region (2021-2032)
  3. 6.2.1 Global Gleevec Sales by Region: 2021-2026
  4. 6.2.2 Global Gleevec Sales by Region (2027-2032)
  5. 6.3 Global Gleevec Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gleevec Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gleevec Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gleevec Sales Value by Region (2027-2032)
  9. 6.5 Global Gleevec Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gleevec Sales Value (2021-2032)
  12. 6.6.2 North America Gleevec Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gleevec Sales Value (2021-2032)
  15. 6.7.2 Europe Gleevec Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gleevec Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gleevec Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gleevec Sales Value (2021-2032)
  21. 6.9.2 South America Gleevec Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gleevec Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gleevec Sales Value Share by Country, 2025 VS 2032
7 Gleevec Country-level Sales and Value Analysis
  1. 7.1 Global Gleevec Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gleevec Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gleevec Sales by Country (2021-2032)
  4. 7.3.1 Global Gleevec Sales by Country (2021-2026)
  5. 7.3.2 Global Gleevec Sales by Country (2027-2032)
  6. 7.4 Global Gleevec Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gleevec Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gleevec Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gleevec Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gleevec Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gleevec Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gleevec Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gleevec Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gleevec Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gleevec Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gleevec Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gleevec Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gleevec Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gleevec Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gleevec Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gleevec Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gleevec Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gleevec Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gleevec Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gleevec Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gleevec Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gleevec Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gleevec Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gleevec Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gleevec Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gleevec Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gleevec Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gleevec Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gleevec Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gleevec Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gleevec Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gleevec Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gleevec Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gleevec Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gleevec Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gleevec Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gleevec Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gleevec Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gleevec Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gleevec Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gleevec Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gleevec Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gleevec Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gleevec Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gleevec Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gleevec Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gleevec Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gleevec Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gleevec Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gleevec Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gleevec Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gleevec Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gleevec Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gleevec Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gleevec Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gleevec Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gleevec Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gleevec Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gleevec Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gleevec Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gleevec Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gleevec Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gleevec Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gleevec Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gleevec Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gleevec Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gleevec Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gleevec Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gleevec Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gleevec Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gleevec Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gleevec Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gleevec Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gleevec Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gleevec Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gleevec Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gleevec Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gleevec Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gleevec Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gleevec Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gleevec Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gleevec Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gleevec Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gleevec Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gleevec Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gleevec Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gleevec Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Gleevec Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Gleevec Product Portfolio
  6. 8.1.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gleevec Value Chain Analysis
  2. 9.1.1 Gleevec Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gleevec Sales Mode & Process
  6. 9.2 Gleevec Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gleevec Distributors
  9. 9.2.3 Gleevec Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research